| ID | Name | CAS | Data |
Inp |
| 116-953-5 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprost-13-enoic acid, MO-TMS # 1
|
|
2 | 2860.00 |
| 116-960-7 |
1-Methyl-N,N-bis(trimethylsilyl)-4-[(trimethylsilyl)oxy]-1H-imidazol-2-amine
|
|
2 | 1548.30 |
| 116-961-6 |
N,9-bis(Trimethylsilyl)-6-[(trimethylsilyl)oxy]-9H-purin-2-amine
|
|
2 | [2101.00; 2125.50] |
| 116-985-0 |
13,14-Dihydro-15-keto-PGF2A, EO-TMS, isomer # 1
|
|
2 | 2732.00 |
| 117-044-3 |
bis-(2,3-Dihydroxypropyl)-(2-hydroxy-1-hydroxyethyl)amine, hexakis-TMS
|
|
2 | 2230.00 |
| 117-133-4 |
4-Chloro-N-(2-hydroxypropionyl)-benzenesulfonamide, N,O-di(trimethylsilyl)-
|
|
2 | 2096.00 |
| 117-205-4 |
Pregnan-20-one, 3,17,21-tris[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
57397-20-3 |
2 | 2981.00 |
| 117-207-2 |
5«beta»-Androstane-3,17-dione, bis-TMS, (3-en)
|
|
2 | [2626.00; 2640.00] |
| 117-233-3 |
Silane, (5«beta»-pregnane-3«alpha»,11«beta»,20«beta»-triyltrioxy)tris[trimethyl-
|
33287-46-6 |
2 | 2941.00 |
| 117-298-2 |
Glycine, N-(3-methyl-1-oxobutyl)-N-(trimethylsilyl)-, trimethylsilyl ester
|
55520-90-6 |
2 | [1510.00; 1529.00] |
| 117-369-3 |
4H-Pyran-4-one, 5-[(trimethylsilyl)oxy]-2-[[(trimethylsilyl)oxy]methyl]-
|
55557-21-6 |
2 | 1686.20 |
| 117-471-9 |
5-Cholesten-3-«beta»,7-«alpha»,12-«alpha»,24,25-pentol, TMS, # 2
|
|
2 | 3582.00 |
| 117-696-0 |
Cholan-24-oic acid, 3-oxo-7,12-bis[(trimethylsilyl)oxy]-, methyl ester, (5«beta»,7«alpha»,12«alpha»)-
|
15093-99-9 |
2 | 3300.00 |
| 117-718-5 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, MO TMS # 2
|
|
2 | 2880.00 |
| 117-731-0 |
5-«alpha»-Pregnan-3-«beta»,16-«alpha»,20-«beta»,21-tetrol, MeTMS
|
|
2 | 3087.00 |
| 117-778-9 |
3-Aminobenzoic acid, N- heptafluorobutyryl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 2046.00 |
| 117-782-4 |
3-Aminobenzoic acid, N,N-bis(acetyl)-, tert.-butyldimethylsilyl ester
|
|
2 | 2124.00 |
| 117-784-2 |
4-Aminobenzoic acid, N- heptafluorobutyryl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 2106.00 |
| 117-958-9 |
15(S)-15-Methyl-PGD2, MO-TMS, isomer # 1
|
|
2 | 2691.00 |
| 118-076-7 |
3-Aminobenzoic acid, N- acetyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 2242.00 |
| 118-164-9 |
Prosta-5,8(12),13-trien-1-oic acid, 9-(ethoxyimino)-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester, (5Z,13E,15S)-
|
56009-44-0 |
2 | 2776.00 |
| 118-182-9 |
13,14-Dihydro-6,15-diketo-PGF1A, MO-TMS, isomer # 1
|
|
2 | 2849.00 |
| 118-307-0 |
2,2,4,6-tetramethyl-4,6-di(2-cyanoethyl)-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 1654.00 |
| 118-446-6 |
2,4-dimethyl-2,4,6,6-tetraphenyl-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 2712.00 |
| 118-450-1 |
1H-Purine-2,6,8(3H)-trione, 4,9-dihydro-1,3,4,9-tetrakis(trimethylsilyl)-
|
55530-45-5 |
2 | [2110.00; 2141.00] |
| 118-501-4 |
3«alpha»,5«beta»,7«alpha», 17«alpha»-tetrahydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 3733.00 |
| 118-556-4 |
1,7-Di(2,5-dichlorophenyl)-2,2,4,4,6,6-hexamethyl-1,3,5,7-tetraoxa-2,4,6-trisilaheptane
|
|
2 | 2540.00 |
| 118-560-9 |
2-Aminobenzoic acid, N- pentafluoropropionyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 1958.00 |
| 118-593-3 |
1H-Indole-3-acetic acid, 1-(trimethylsilyl)-5-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55268-67-2 |
2 | [2168.00; 2249.00] |
| 118-652-7 |
D-(+)-Glucuronic acid «gamma»-lactone, tris(trimethylsilyl) ether, methyloxime (anti)
|
|
2 | 1921.00 |
| 118-653-6 |
D-(+)-Glucuronic acid «gamma»-lactone, tris(trimethylsilyl) ether, methyloxime (syn)
|
|
2 | 1894.40 |
| 118-989-4 |
Nigerotriose: aD-Glcp(1->3)-aDGlcp(1->3)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 3412.00 |
| 119-043-2 |
1,8-Dihydroxy-6-methoxy-3-methylanthraquinone, O,O'-bis(trimehylsilyl)
|
7336-75-6 |
2 | 2836.00 |
| 119-106-2 |
6'-Glucosyl-cellobiose: aD-Glcp(1->6)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 3477.00 |
| 119-222-3 |
15(S)-15-Methyl-PGD2, EO-TMS, isomer # 2
|
|
2 | 2772.00 |
| 119-271-9 |
Octanoic acid, 2-[(tert-butyldimethylsilyl)oxy]-, tert-butyldimethylsilyl ester, (.+/-.)-
|
|
2 | 1864.20 |
| 119-351-0 |
6'-Glucosyl-cellobiose: aD-Glcp(1->6)-bDGlcp(1->4)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 3439.00 |
| 119-366-4 |
4-Methylvaleric acid, dimethyl(3,3,3-trifluoropropyl)silyl ester
|
|
2 | 1162.00 |
| 119-456-4 |
2,2-dimethyl-4,4,6,6-tetraphenyl-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 2720.00 |
| 119-698-6 |
Benzoic acid, 2,3-bis[(tert-butyldimethylsilyl)oxy]-, tert-butyldimethylsilyl ester
|
|
2 | 2408.00 |
| 119-751-6 |
3-Aminobenzoic acid, N- pentafluoropropionyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 2038.00 |
| 119-805-6 |
Talonic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55515-31-6 |
2 | 1959.00 |
| 119-884-9 |
Prosta-8(12),13-dien-1-oic acid, 9-(methoxyimino)-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
72150-31-3 |
2 | 2696.00 |
| 119-927-1 |
Lactosucrose: bD-Galp(1->4)-aDGlcp(1->2)-bFru, oxime-TMS
|
|
2 | 3211.00 |
| 120-000-7 |
Butanoic acid, 4,4'-dithiobis[2-[(trimethylsilyl)amino]-, bis(trimethylsilyl) ester, [S-(R*,R*)]-
|
69688-45-5 |
2 | [2512.40; 2577.00] |
| 120-016-0 |
Nonanamide, N-[[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]methyl]-8-methyl-
|
56784-16-8 |
2 | 2663.40 |
| 120-048-5 |
15(S)-15-Methyl-PGD2, MO-TMS, isomer # 2
|
|
2 | 2717.00 |
| 120-061-0 |
Adenosine, N-(trimethylsilyl)-2',3'-bis-O-(trimethylsilyl)-, 5'-[bis(trimethylsilyl) phosphate]
|
32653-14-8 |
2 | [3114.00; 3115.00] |
| 120-185-3 |
1,6-Dihydroxy-8-methoxy-3-methylanthraquinone, O,O'-bis(trimethylsilyl)-
|
91701-23-4 |
2 | 2846.00 |
| 120-209-6 |
3«alpha»,5«beta»,7«alpha»,12«alpha»-tetrahydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 3663.00 |
| 120-247-4 |
Androst-4-en-9«alpha»-fluoro-17«alpha»-methyl-3«alpha»,6«beta»,11«beta»,17«beta»-tetraol, TMS
|
|
2 | 2858.00 |
| 120-248-3 |
6'-Galactosyl-lactose: bD-Galp(1->6)-bDGalp(1->4)-DGlu, oxime-TMS, isomer # 1
|
|
2 | 3417.00 |
| 120-556-1 |
Silica-1,3,5,7-tetramethyl-2,4,6,8-tetraethylporphyrine complex, bis-OTMS
|
|
2 | 3330.00 |
| 120-608-3 |
5-Pyrimidinecarboxylic acid, 2,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
56804-96-7 |
2 | 1780.00 |
| 120-685-8 |
d-Fructose, 1,3,4,5-tetrakis-O-(trimethylsilyl)-, o-methyloxime, 6-[bis(trimethylsilyl) phosphate]
|
55530-74-0 |
2 | 2321.00 |
| 120-737-0 |
Androst-5-en-11-one, 3,17-bis[(trimethylsilyl)oxy]-, (3«beta»,17«beta»)-
|
49774-90-5 |
2 | 2620.00 |
| 120-748-8 |
Pentanoic acid, 3-oxo-2-propyl, enol-bis-TMS, # 2
|
|
2 | 1429.00 |
| 121-049-3 |
3,5-Dioxa-4-phospha-2-silaheptan-7-oic acid, 2,2-dimethyl-4-[(trimethylsilyl)oxy]-6-[[(trimethylsilyl)oxy]methyl]-, trimethylsilyl ester, 4-oxide
|
|
2 | 1797.00 |
| 121-103-2 |
Silane, dimethyl(dimethyl(but-2-enyloxy)silyloxy)(but-2-enyloxy)-
|
|
2 | 1303.00 |
| 121-178-0 |
3-hydroxy-4-methylglutamic acid, N(O,S)-isoBOC TBDMS, diastreoisomer 2
|
|
2 | 2514.30 |
| 121-196-0 |
2,4,6-trimethyl-2,4,6,8,8-pentaphenyl-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 3220.00 |
| 121-204-0 |
15(S)-15-Methyl-PGA2, BO-TMS, isomer # 2
|
|
2 | 2845.00 |
| 121-258-1 |
Formebelone M (Androst-1,4-dien-2z-hydroxymethyl-17A-methyl-11A,17B-diol-3-one), TMS
|
|
2 | 3096.00 |
| 121-261-7 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprost-13-enoic acid, 19-hydroxy, MO-TMS # 1
|
|
2 | 3040.00 |
| 121-276-1 |
Trimethylsilyl 2-amino-3-(3-chloro-4-[(trimethylsilyl)oxy]phenyl)propanoate
|
|
2 | 2062.00 |
| 121-411-0 |
Glycine, N-(3-methyl-1-oxo-2-butenyl)-, trimethylsilyl ester
|
|
2 | [1539.00; 1575.00] |
| 121-508-3 |
2,2,4,4,6,8-hexamethyl-6,8-di(2-cyanoethyl)-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 1797.00 |
| 121-523-6 |
D-Mannose, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, O-methyloxime, 6-[bis(trimethylsilyl) phosphate]
|
55530-76-2 |
2 | 2324.00 |
| 121-528-1 |
5-Pregnan-11-one, 3«alpha»,20«alpha»,21-trihydroxy, TMSO-TMS
|
|
2 | 3089.00 |
| 121-532-6 |
27-nor-5-«beta»-Cholestan-3-«alpha»,7-«alpha»,12-«alpha»,24,25-pentol, TMS, # 1
|
|
2 | 3466.00 |
| 121-550-6 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)isobutoxy-
|
|
2 | 1489.00 |
| 121-552-4 |
Silane, dimethyl(dimethyl(non-5-yn-3-yloxy)silyloxy)isobutoxy-
|
|
2 | 1592.00 |
| 121-562-3 |
3,20-Dioxo-11«beta»,18-epoxy-17«alpha»,18,21-trihydroxy-4-pregnene, MO-TMS, syn
|
|
2 | 3228.00 |
| 121-580-3 |
«alpha»-D-Glucopyranose, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, bis(trimethylsilyl) phosphate
|
55520-79-1 |
2 | 2260.00 |
| 121-771-1 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, 19-hydroxy, MO-TMS # 2
|
|
2 | 3120.00 |
| 121-795-5 |
4-Pentenoic acid, 2-(1-oxopropyl), enol-bis-TMS, # 2
|
|
2 | 1435.00 |
| 121-804-4 |
Pyrimidine, 2,4-dihydroxy-6-oxo-5,5-diethyl, TMS
|
|
2 | 1608.00 |
| 121-884-6 |
Silane, [[(17«beta»)-androsta-3,5-diene-3,17-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
|
64898-31-3 |
2 | [3241.00; 3300.00] |
| 121-893-6 |
Benzeneacetic acid, 3-methoxy-«alpha»,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
|
2 | [1859.70; 1910.00] |
| 121-980-9 |
5-Pregnan-11-one, 3«alpha»,20«alpha»,21-trihydroxy, EO-TMS
|
|
2 | 3085.00 |
| 121-991-7 |
L-Tyrosine, N,O-bis(trimethylsilyl)-3-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55638-45-4 |
2 | [2081.40; 2124.00] |
| 122-004-1 |
13,14-Dihydro-15-keto-PGF1A, EO-TMS, isomer # 2
|
|
2 | 2799.00 |
| 122-050-0 |
3«alpha»,7«alpha»,12«alpha»,25-tetrahydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
|
2 | 3628.00 |
| 122-063-6 |
4-(2-Hydroxyethyl)-2,2-dimethyl-1,3-dioxolane, (3-cyanopropyl)dimethylsilyl ether
|
|
2 | 1726.00 |
| 122-177-0 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, 19-hydroxy, EO-TMS # 2
|
|
2 | 3145.00 |
| 122-220-1 |
1,3-Disiloxane, 1,3-dimethyl, 1,3-bis-(chloromethyl), 1,3-bis-(2-chloroethyl)
|
|
2 | 1590.00 |
| 122-247-2 |
13,14-Dihydro-15-keto-PGF2A, EO-TMS, isomer # 2
|
|
2 | 2755.00 |
| 122-280-5 |
9-Oxo-11-octadecenoic acid, 13-hydroxy, PFBO, TMS, methyl ester, # 1
|
|
2 | 2856.00 |
| 122-330-9 |
Phosphoric acid, 2-(trimethylsiloxy)-1-[(trimethylsiloxy)methyl]ethyl bis(trimethylsilyl) ester
|
|
2 | 1741.00 |
| 122-337-2 |
N-(2-Hydroxy-1-phenyl-ethyl)-benzenesulfonamide, N,O-di(trimethylsilyl)-
|
|
2 | 2480.00 |
| 122-427-2 |
1,3(5«beta»)-androsten-3,17«beta»-diol di-TMS
|
|
2 | [2467.00; 2493.00] |
| 122-472-2 |
Disiloxane, 1,1,3,3-tetramethyl-1,3-bis(pentafluorophenyl)-
|
19091-32-8 |
2 | 1585.00 |
| 122-595-6 |
1-Chloro-3-methoxy-propan-2-ol, tert-butyldimethylsilyl ether
|
|
2 | 1259.00 |
| 122-731-4 |
13,14-Dihydro-15-keto-PGF2A, MO-TMS, isomer # 2
|
|
2 | 2712.00 |
| 122-761-1 |
2,3-Dihydroxypropyl-(2-hydroxy-1-hydroxymethyl)ethylamine, tetrakis-TMS
|
|
2 | 1810.00 |
| 122-820-5 |
Glycine, N-(2-methyl-1-oxo-2-butenyl)-N-(trimethylsilyl)-, trimethylsilyl ester, (E)-
|
55517-45-8 |
2 | [1549.00; 1579.00] |
| 123-128-3 |
Methyl 5-«beta»-cholan-3,7-dione-24-oate, oxime, TMS # 2
|
|
2 | 3392.00 |
| 123-147-2 |
Silane, diphenylisohexyloxy(2,2,3,3,4,4,5,5-octafluoropentyloxy)-
|
|
2 | 2083.00 |
| 123-195-9 |
Prosta-8(12),13-dien-1-oic acid, 9-oxo-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester, (13E,15S)-
|
56009-41-7 |
2 | 2880.00 |
| 123-212-9 |
trans-3-Hydroxycinnamic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
2 | 2349.00 |
|
« Previous Results
Next Results »
|